Home > Insider Trading > Filing (0001179110-13-006930)

Filing Details

Accession Number:: 0001179110-13-006930
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-17 20:58:28
Reporting Period:: 2013-04-16

Filing Date:: 2013-04-17
Accepted Time:: 2013-04-17 20:58:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1477598	Omthera Pharmaceuticals Inc.	OMTH	Pharmaceutical Preparations (2834)	263797738

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1402054	Gerald Wisler	C/O Omthera Pharmaceuticals, Inc. 707 State Road Princeton NJ 08540	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-04-16	36,574	$0.00	645,761	No	4	C	Direct
Common Stock	Acquisiton	2013-04-16	3,125	$0.01	648,886	No	4	C	Direct
Common Stock	Disposition	2013-04-16	4	$8.00	648,882	No	4	S	Direct
Common Stock	Acquisiton	2013-04-16	12,664	$8.00	661,546	No	4	C	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	S	Direct
No	4	C	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Convertible Preferred Stock	Disposition	2013-04-16	51,033	$0.00	36,574	$0.00
Common Stock	Warrant (right to buy)	Disposition	2013-04-16	3,125	$0.00	3,125	$0.01
Common Stock	Secured Convertible Promissory Note	Disposition	2013-04-16	12,664	$0.00	12,664	$8.00

Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
		No	4	C	Direct
2013-04-16	2023-02-15	No	4	C	Direct
2013-04-16	2014-02-15	No	4	C	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	331,963	Indirect	By Nicole Miranda Wisler 2012 Exempt Trust
Common Stock	26,382	Indirect	By Nicole Miranda Wisler 2012 Non-Exempt Trust
Common Stock	331,963	Indirect	By Michael Robert Wisler 2012 Exempt Trust
Common Stock	26,382	Indirect	By Michael Robert Wisler 2012 Non-Exempt Trust

Footnotes

Represents the total number of shares received upon conversion of shares of the Issuer's Series B Convertible Preferred Stock (the "Series B Shares").
Represents the total number of shares received upon conversion of the reporting person's warrant.
Effective upon the closing of the Issuer's initial public offering ("IPO") of its Common Stock, the reporting person's warrant automatically converted into 3,125 shares of Common Stock. The reporting person paid the exercise price of $0.01 per share of the warrant on a cashless basis, resulting in the Issuer's withholding of 4 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 3,121 shares.
Represents the total number of shares received upon conversion of the Secured Convertible Promissory Note issued to the reporting person.
These shares are held in a trust for the benefit of one of the reporting person's children. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, except to the extent of the reporting person's pecuniary interest, if any, therein, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Effective upon the closing of the Issuer's IPO of its Common Stock, each Series B Share automatically converted at a ratio of 1.3953-to-1 into the number of shares of Common Stock shown in column 7. The Series B Shares had no expiration date.
This is the maturity date of the Secured Convertible Promissory Note.
The Secured Convertible Promissory Note was issued to the reporting person in exchange for $100,000. Effective upon the closing of the Issuer's IPO of its Common Stock, the Secured Convertible Promissory Note automatically converted into the number of shares of Common Stock shown in column 7.